 | Cortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022 - Business Wire
businesswire.com - July 27 at 3:47 PM |
| Cortexyme Successfully Completes Phase 1 Single and Multiple Ascending Dose Clinical Trial of COR588 - Business Wire
businesswire.com - July 27 at 3:47 PM |
 | Cortexyme Successfully Completes Phase 1 Single and Multiple Ascending Dose Clinical Trial of COR588 - Yahoo Finance
finance.yahoo.com - July 27 at 10:45 AM |
| Cortexyme Successfully Completes Phase 1 Single and Multiple Ascending Dose Clinical Trial of COR588
finance.yahoo.com - July 27 at 10:44 AM |
| Cortexyme Corporate Name Change to Quince Therapeutics to Take Effect on August 1, 2022
finance.yahoo.com - July 27 at 10:44 AM |
 | Cortexyme (CRTX) Announces Resignation of EVP of Research and Development - StreetInsider.com
streetinsider.com - July 22 at 10:41 PM |
 | Cortexyme Announces Preclinical Data Demonstrating Efficacy Of Cor803 For The Treatment Of Coronavirus In - Benzinga
benzinga.com - June 21 at 11:52 AM |
 | Cortexyme : Preclinical Data Show Efficacy Of COR803 For Coronavirus Infections Treatment - Nasdaq
nasdaq.com - June 21 at 11:52 AM |
| Cortexyme Announces Preclinical Data Demonstrating Efficacy of COR803 for the Treatment of Coronavirus Infections
finance.yahoo.com - June 21 at 11:52 AM |
|
| Cortexyme Appoints June Bray to its Board of Directors - Business Wire
businesswire.com - June 13 at 3:34 PM |
| Cortexyme Appoints June Bray to its Board of Directors - Yahoo Finance
finance.yahoo.com - June 13 at 10:33 AM |
| Cortexyme Appoints June Bray to its Board of Directors
finance.yahoo.com - June 13 at 10:33 AM |
| Cortexyme Successfully Completes Acquisition of Novosteo - Business Wire
businesswire.com - May 22 at 5:27 PM |
| This Is the Worst Type of Credit Card for Most Consumers - Nasdaq
nasdaq.com - May 20 at 5:28 PM |
| PPG Showcases Innovations in Paints, Coatings, Specialty Materials That Enhance Sustainability, Efficiency, Mobility - Yahoo Finance
finance.yahoo.com - May 20 at 9:21 AM |
| Cortexyme Successfully Completes Acquisition of Novosteo - Yahoo Finance
finance.yahoo.com - May 20 at 9:21 AM |
| Cortexyme Appoints Dr. Philip Low to Its Board of Directors
finance.yahoo.com - May 20 at 9:21 AM |
| Pre-market Movers: EBET, AFRM, CELU, FIGS, LLAP… - Nasdaq
nasdaq.com - May 13 at 3:32 PM |
| Cortexyme to Participate at 4th International Conference on Porphyromonas gingivalis and Related Species in Oral and Systemic Diseases - Yahoo Finance
finance.yahoo.com - May 12 at 10:14 AM |
| Cortexyme to Participate at 4th International Conference on Porphyromonas gingivalis and Related Species in Oral and Systemic Diseases
finance.yahoo.com - May 12 at 10:14 AM |
| Form 10-Q Cortexyme, Inc. For: Mar 31 - StreetInsider.com
streetinsider.com - May 11 at 1:09 AM |
| Cortexyme Announces Agreement to Acquire Novosteo - StreetInsider.com
streetinsider.com - May 11 at 1:09 AM |
 | Tuesday Digest: Prologis attempts hostile buyout of Duke; Salesforce's latest buy - San Francisco Business Times - The Business Journals
bizjournals.com - May 10 at 2:57 PM |
| Cortexyme Announces Agreement to Acquire Novosteo
finance.yahoo.com - May 10 at 9:56 AM |
| Bragar Eagel & Squire, P.C. Is Investigating Agrify, CareDx, Medallion, and Cortexyme and Encourages Investors to Contact the Firm
benzinga.com - May 6 at 9:43 PM |
| Is Cortexyme (NASDAQ:CRTX) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - May 6 at 3:29 PM |
| The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Appl - Benzinga
benzinga.com - May 3 at 1:35 PM |
| Cortexyme Announces Further Layoffs, Chief Medical Officer Leaves
benzinga.com - May 3 at 10:17 AM |
| Bragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Cortexyme, and Corcept and Encourages Investors to Contact the Firm
benzinga.com - May 1 at 9:38 PM |
| Cortexyme, Inc. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - Benzinga
benzinga.com - April 28 at 1:44 PM |
|
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cortexyme, Inc. - CRTX - Benzinga
benzinga.com - April 23 at 9:08 PM |
 | Bragar Eagel & Squire, PC Is Investigating CareDx, Medallion, Cortexyme, and SelectQuote and Encourages Investors to Contact the Firm - GlobeNewswire
globenewswire.com - April 15 at 9:03 PM |
| Bragar Eagel & Squire, P.C. Is Investigating Medallion, Cortexyme, SelectQuote, and Corcept and Encourage - Benzinga
benzinga.com - April 11 at 10:31 AM |
| Bragar Eagel & Squire, PC Is Investigating Medallion, - GlobeNewswire
globenewswire.com - April 10 at 11:33 PM |
| HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Cortexyme, Inc. (CRTX) For Possible Securities Law Violations, Encourages Investors With Significant Losses to Contact Firm - GlobeNewswire
globenewswire.com - March 28 at 6:26 PM |
| Bragar Eagel & Squire, PC Is Investigating Sea, - GlobeNewswire
globenewswire.com - March 27 at 12:11 PM |
| Bragar Eagel & Squire, P.C. Is Investigating Sea, Cortexyme, and RBB and Encourages Investors to Contact the Firm
benzinga.com - March 25 at 9:49 PM |
| CRTX SHAREHOLDER ALERT: ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Cortexyme, Inc. Investors with Loss - Benzinga
benzinga.com - March 22 at 4:45 AM |
| Cortexyme Provides New GAIN Trial Data at AD/PD 2022 Demonstrating Potential Benefit of Lysine Gingipain - Benzinga
benzinga.com - March 22 at 4:45 AM |
| Cortexyme Provides New GAIN Trial Data at AD/PD 2022 Demonstrating Potential Benefit of Lysine Gingipain Inhibition in Mild to Moderate Alzheimer’s Population
finance.yahoo.com - March 21 at 1:10 PM |
| CRTX INVESTOR ALERT: Hagens Berman, National Trial - GlobeNewswire
globenewswire.com - March 19 at 6:27 PM |
| CRTX INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Investigating Cortexyme, Inc. (CRTX) For Possible Securities Law Violations, Encourages Investors With Significant Losses to Contact Firm
benzinga.com - March 19 at 10:59 AM |
| Cortexyme to Present New GAIN Trial Data at AD/PD 2022 - Business Wire
businesswire.com - March 16 at 8:57 AM |
| Cortexyme Appoints Marwan Sabbagh, MD, to its Board of Directors
finance.yahoo.com - March 15 at 12:55 PM |
| Bragar Eagel & Squire, P.C. Is Investigating Cortexyme, FAT Brands, Koppers, and RBB and Encourages Investors to Contact the Firm
benzinga.com - March 14 at 10:18 PM |
| Bragar Eagel & Squire, PC Is Investigating Cortexyme, FAT Brands, Koppers, and RBB and Encourages Investors to Contact the Firm - GlobeNewswire
globenewswire.com - March 14 at 9:54 PM |
| Cortexyme to Present New GAIN Trial Data at AD/PD 2022 - Benzinga - Benzinga
benzinga.com - March 14 at 4:53 PM |
| Cortexyme to Present New GAIN Trial Data at AD/PD 2022 - Yahoo Finance
finance.yahoo.com - March 14 at 8:49 AM |
| Cortexyme to Present New GAIN Trial Data at AD/PD 2022
finance.yahoo.com - March 14 at 8:49 AM |
| Nordic Nanovector Announces Presentation of Preclinical Data on Alpha37, at the American Association for Cancer Research 2022 Annual Meeting - Yahoo Finance
finance.yahoo.com - March 9 at 9:20 AM |
